German pharmaceutical giant Bayer recently announced the launch of a 'first-of-its-kind' PET blister pack for its Aleve drug ...

U.S. farmers struggling with slumping incomes and depressed grain prices have been switching to cheaper generic pesticides ...

Approximately €70 Million in Upfront and Near-term Payments to CytokineticsUp to €490 Million in Commercial Milestone Payments, withTiered ...

Channel Edge is a downstream blend of individually registered soybean seed treatment products and a combination of four ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Bayer AG (BAYRY) reports strong performance in Pharmaceuticals and Consumer Health, while facing headwinds in Crop Science ...

So much easier to use the brand name as shorthand, isn’t it ... The drug, derived from morphine, was named ‘heroin’, ...

Stivarga (BAY 73-4506) is the brand name for the generic chemotherapy agent regorafenib ... previously received imatinib mesylate and sunitinib malate. In September 2021, Bayer presented study results ...

The study confirmed that Afqlir has equivalent efficacy and comparable safety to its reference medicine, Eylea.

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Moberg Pharma's MOB-015 has outstanding clinical trial data, 76% cure rate, double the current standard topical, Jublia. Read ...